Susceptibility-weighted imaging: technical essentials and clinical neurologic applications

S Haller, EM Haacke, MM Thurnher, F Barkhof - Radiology, 2021 - pubs.rsna.org
Susceptibility-weighted imaging (SWI) evolved from simple two-dimensional T2*-weighted
sequences to three-dimensional sequences with improved spatial resolution and enhanced …

Neuroimaging in dementia: more than typical Alzheimer disease

S Haller, HR Jäger, MW Vernooij, F Barkhof - Radiology, 2023 - pubs.rsna.org
Alzheimer disease (AD) is the most common cause of dementia. The prevailing theory of the
underlying pathology assumes amyloid accumulation followed by tau protein aggregation …

Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes

YJ Bae, JM Kim, CH Sohn, JH Choi, BS Choi, YS Song… - Radiology, 2021 - pubs.rsna.org
Parkinson disease is characterized by dopaminergic cell loss in the substantia nigra of the
midbrain. There are various imaging markers for Parkinson disease. Recent advances in …

Neuroimaging in Lewy body dementia

T Yousaf, G Dervenoulas, PE Valkimadi, M Politis - Journal of neurology, 2019 - Springer
Lewy body dementia (DLB) is a common form of cognitive impairment, accounting for 30% of
dementia cases in ages over 65 years. Early diagnosis of DLB has been challenging; …

Biomarkers of dementia with Lewy bodies: differential diagnostic with Alzheimer's disease

O Bousiges, F Blanc - International Journal of Molecular Sciences, 2022 - mdpi.com
Dementia with Lewy Bodies (DLB) is a common form of cognitive neurodegenerative
disease. Only one third of patients are correctly diagnosed due to the clinical similarity …

Multimodality imaging of dementia: clinical importance and role of integrated anatomic and molecular imaging

KP Patel, DT Wymer, VK Bhatia, R Duara… - Radiographics, 2020 - pubs.rsna.org
Neurodegenerative diseases are a devastating group of disorders that can be difficult to
accurately diagnose. Although these disorders are difficult to manage owing to relatively …

Clinical 7 Tesla magnetic resonance imaging: Impact and patient value in neurological disorders

E de Vries, C Hagbohm, R Ouellette… - Journal of Internal …, 2025 - Wiley Online Library
Magnetic resonance imaging (MRI) is a cornerstone of non‐invasive diagnostics and
treatment monitoring, particularly for diseases of the central nervous system. Although 1.5 …

Complete evaluation of dementia: PET and MRI correlation and diagnosis for the neuroradiologist

JD Oldan, VL Jewells, B Pieper… - American journal of …, 2021 - Am Soc Neuroradiology
This article will familiarize neuroradiologists with the pathophysiology, clinical findings, and
standard MR imaging and PET imaging features of multiple forms of dementia as well as …

Structural imaging in Parkinson's disease: new developments

S Prange, E Metereau, S Thobois - Current Neurology and Neuroscience …, 2019 - Springer
Abstract Purpose of Review To review the advances in structural imaging for the diagnosis,
prognosis, and treatment of Parkinson's disease (PD) during the last 5 years. Recent …

MRI quantitative susceptibility map** of the substantia nigra as an early biomarker for Lewy body disease

Q Chen, BF Boeve, A Forghanian‐Arani… - Journal of …, 2021 - Wiley Online Library
ABSTRACT Background and Purpose Neurodegeneration of the substantia nigra in Lewy
body disease is associated with iron deposition, which increases the magnetic susceptibility …